Enanta Pharmaceuticals Navigates Market Volatility with Strategic Focus on Viral and Liver Disease Therapies
Enanta Pharmaceuticals continues to navigate market fluctuations with a strategic focus on developing small molecule drugs for viral infections and liver diseases, positioning itself for growth and success in the biotech industry.
2 minutes to read